Medical Devices
veneX Precision in Every Vein
A non-thermal, bioabsorbable embolization agent combined with the VenexCath delivery platform — closing varicose veins in a single endovascular procedure, without anesthesia, surgical incision, or post-treatment compression stockings.
vein closure
30 minutes
required
of varicose veins
Endovascular
Closure
Three configurations delivering the complete non-thermal endovascular solution — from stand-alone embolization agent to fully integrated kit with precision delivery catheter.
A streamlined endovascular procedure performed under ultrasound guidance — from single-entry access to walking discharge in under 30 minutes.
VenexCath is advanced via the knee lid under ultrasound guidance to the groin, reaching the target vessel without anesthesia or narcosis.
The self-echogenic braided micro catheter provides continuous real-time visibility. The kink-resistant design ensures precise positioning at the treatment site.
Venex high-density bioabsorbable agent is administered intravenously over 5–10 minutes. Polymerisation achieves total vascular closure in a single application.
No hospital stay required. No compression stockings. No pain management needed post-procedure. The patient leaves on foot within 30 minutes of intervention.
Laser ablation and radiofrequency treatments carry inherent thermal risk profiles that Venex eliminates by design.
Thermal methods require cold liquid injection with local anesthetic around the vessel due to heat generation. Venex requires none — shorter procedure, less patient discomfort.
Laser and RF treatments can cause thermal damage, nerve injury, numbness, and skin burns — especially near superficial saphenous veins. Venex uses no heat energy whatsoever.
In small saphenous vein (Vena Saphena Parva) treatment, the N.Suralis proximity creates high nerve damage risk with thermal methods. Non-thermal peripheral embolization eliminates this entirely.
The vein closes in one application via polymerisation. No repeat treatments. No staged procedures. Vascular total closure with a single administration of embolization agent.
Patients resume their lives immediately. No hospital admission, no compression stockings, no post-procedure pain management. Walk-in, walk-out treatment.
The agent is fully bioabsorbable and does not contain DMSO, the toxic carrier solvent used in many competing embolization products. Clean chemistry, better patient tolerance.
Set Components
Every component required for the complete endovascular procedure — supplied sterile in a single kit.
Volume Range
Six volumes allow precise dosing matched to the target vessel diameter and treatment length.
Registered by EPG Pharma Ltd as UK Responsible Person.
Varicose vein adhesive-treatment kit — Class III Medical Device
Interested in Stocking
the Venex System?
Contact the EPG Pharma team for wholesale pricing, product specifications, procedure training support, or to request clinical samples.